Bank of New York Mellon’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.2M | Buy |
43,114
+4,637
| +12% | +$109K | ﹤0.01% | 3255 |
|
|
2026
Q1 | $831K | Sell |
38,477
-80
| -0.2% | -$1.48K | ﹤0.01% | 3325 |
|
|
2025
Q4 | $529K | Sell |
38,557
-449
| -1% | -$7K | ﹤0.01% | 3581 |
|
|
2025
Q3 | $690K | Sell |
39,006
-1,264
| -3% | -$20K | ﹤0.01% | 3420 |
|
|
2025
Q2 | $608K | Buy |
40,270
+1,943
| +5% | +$32.2K | ﹤0.01% | 3402 |
|
|
2025
Q1 | $617K | Sell |
38,327
-484
| -1% | -$9.02K | ﹤0.01% | 3348 |
|
|
2024
Q4 | $676K | Sell |
38,811
-1,529
| -4% | -$27K | ﹤0.01% | 3367 |
|
|
2024
Q3 | $708K | Sell |
40,340
-10,574
| -21% | -$180K | ﹤0.01% | 3325 |
|
|
2024
Q2 | $570K | Buy |
50,914
+9,639
| +23% | +$90.8K | ﹤0.01% | 3512 |
|
|
2024
Q1 | $360K | Sell |
41,275
-4,854
| -11% | -$44.6K | ﹤0.01% | 3702 |
|
|
2023
Q4 | $565K | Sell |
46,129
-5,826
| -11% | -$40.3K | ﹤0.01% | 3487 |
|
|
2023
Q3 | $209K | Buy |
51,955
+690
| +1% | +$4.29K | ﹤0.01% | 3944 |
|
|
2023
Q2 | $369K | Buy |
+51,265
| New | +$327K | ﹤0.01% | 3748 |
|
|
2022
Q2 | – | Sell |
-41,208
| Closed | -$200K | – | 4675 |
|
|
2022
Q1 | $200K | Buy |
41,208
+655
| +2% | +$5.36K | ﹤0.01% | 4241 |
|
|
2021
Q4 | $601K | Buy |
40,553
+806
| +2% | +$16.1K | ﹤0.01% | 3681 |
|
|
2021
Q3 | $858K | Buy |
39,747
+1,438
| +4% | +$30.9K | ﹤0.01% | 3482 |
|
|
2021
Q2 | $629K | Buy |
38,309
+1,248
| +3% | +$23.8K | ﹤0.01% | 3661 |
|
|
2021
Q1 | $878K | Sell |
37,061
-28
| -0.1% | -$837 | ﹤0.01% | 3404 |
|
|
2020
Q4 | $885K | Sell |
37,089
-1,819
| -5% | -$28.9K | ﹤0.01% | 3319 |
|
|
2020
Q3 | $458K | Sell |
38,908
-1,788
| -4% | -$19.2K | ﹤0.01% | 3536 |
|
|
2020
Q2 | $426K | Buy |
40,696
+9,116
| +29% | +$82.1K | ﹤0.01% | 3555 |
|
|
2020
Q1 | $226K | Sell |
31,580
-125
| -0.4% | -$1.3K | ﹤0.01% | 3704 |
|
|
2019
Q4 | $426K | Buy |
31,705
+1,389
| +5% | +$19.8K | ﹤0.01% | 3668 |
|
|
2019
Q3 | $468K | Sell |
30,316
-1,150
| -4% | -$14.9K | ﹤0.01% | 3572 |
|
|
2019
Q2 | $415K | Sell |
31,466
-27,965
| -47% | -$382K | ﹤0.01% | 3692 |
|
|
2019
Q1 | $1.05M | Buy |
59,431
+2,097
| +4% | +$32.9K | ﹤0.01% | 3145 |
|
|
2018
Q4 | $657K | Sell |
57,334
-8,950
| -14% | -$108K | ﹤0.01% | 3338 |
|
|
2018
Q3 | $940K | Buy |
66,284
+4,734
| +8% | +$67.3K | ﹤0.01% | 3302 |
|
|
2018
Q2 | $932K | Buy |
61,550
+5,127
| +9% | +$86.8K | ﹤0.01% | 3284 |
|
|
2018
Q1 | $763K | Buy |
56,423
+162
| +0.3% | +$3.08K | ﹤0.01% | 3352 |
|
|
2017
Q4 | $1.33M | Buy |
56,261
+694
| +1% | +$16.4K | ﹤0.01% | 3081 |
|
|
2017
Q3 | $1.03M | Buy |
55,567
+29,588
| +114% | +$672K | ﹤0.01% | 3210 |
|
|
2017
Q2 | $897K | Buy |
+25,979
| New | +$714K | ﹤0.01% | 3306 |
|
Other funds holding PLSE
GAM
WIM
AWA
FFA
GCP
Bank of New York Mellon's PLSE Position: Q2 2026 in Review
Bank of New York Mellon increased its Pulse Biosciences (PLSE) stake by 12% in Q2 2026, buying an estimated $109K and bringing the position to 43,114 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3255.
Bank of New York Mellon first reported a position in PLSE in Q2 2017 and has held it in 33 quarters since. The position peaked at $1.33M in Q4 2017. 37 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.
- Bank of New York Mellon held 43,114 shares of Pulse Biosciences worth $1.2M as of Q2 2026.
- Bank of New York Mellon bought 4,637 Pulse Biosciences shares in Q2 2026, an estimated $109K.
- Pulse Biosciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3255 holding.
- Bank of New York Mellon first reported a position in Pulse Biosciences in Q2 2017 and has held it in 33 quarters since.
- Bank of New York Mellon's Pulse Biosciences position peaked at $1.33M in Q4 2017.
- 37 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.